TAMOXIFEN THERAPY IN PRIMARY BREAST-CANCER - BIOLOGY, EFFICACY, AND SIDE-EFFECTS

[81] OSBORNE CK, 1983, CANCER RES, V43, P3583

[82] Palshof T., 1985, REV ENDOCR REL CAN S, V17, P43

[83] PATTERSON JS, 1987, REV ENDOCR REL CANCE, V20, P57

[84] REVERSIBLE CENTRAL NERVOUS-SYSTEM DYSFUNCTION DUE TO TAMOXIFEN IN A PATIENT WITH BREAST-CANCER [J]. ANNALS OF INTERNAL MEDICINE, 1984, 101 (05) : 652 - 652

[85] POWLES TJ, 1986, LANCET, V2, P344

[86] PUGESGAARD T, 1986, CANCER-AM CANCER SOC, V58, P383, DOI 10.1002/1097-0142(19860715)58:2<383::AID-CNCR2820580232>3.0.CO

[87] 2-I

[88] RATTEL B, 1987, COMP TOXICOLOGY DROL

[89] RENNER KN, 1985, REV ENDOCR REL CAN S, V17, P123

[90] THE CHRISTIE-HOSPITAL TAMOXIFEN (NOLVADEX) ADJUVANT TRIAL FOR OPERABLE BREAST-CARCINOMA - 7-YR RESULTS [J]. EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1985, 21 (08): : 897 - 900

[81] OSBORNE CK, 1983, CANCER RES, V43, P3583

[82] Palshof T., 1985, REV ENDOCR REL CAN S, V17, P43

[83] PATTERSON JS, 1987, REV ENDOCR REL CANCE, V20, P57

[84] REVERSIBLE CENTRAL NERVOUS-SYSTEM DYSFUNCTION DUE TO TAMOXIFEN IN A PATIENT WITH BREAST-CANCER [J]. ANNALS OF INTERNAL MEDICINE, 1984, 101 (05) : 652 - 652

[85] POWLES TJ, 1986, LANCET, V2, P344

[86] PUGESGAARD T, 1986, CANCER-AM CANCER SOC, V58, P383, DOI 10.1002/1097-0142(19860715)58:2<383::AID-CNCR2820580232>3.0.CO

[87] 2-I

[88] RATTEL B, 1987, COMP TOXICOLOGY DROL

[89] RENNER KN, 1985, REV ENDOCR REL CAN S, V17, P123

[90] THE CHRISTIE-HOSPITAL TAMOXIFEN (NOLVADEX) ADJUVANT TRIAL FOR OPERABLE BREAST-CARCINOMA - 7-YR RESULTS [J]. EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1985, 21 (08): : 897 - 900